Musculoskeletal

Headache Relief Shampoo Voted #1 Best New Product in 2019

headache relief shampoo bottles

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019Comments OffHeadache Drug Trial | Headache Relief | Headache Shampoo | Headache Study | Headache Therapy
Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients

Conditions:   Knee Osteoarthritis;   Knee Pain Chronic;   Knee Arthritis
Intervention:   Device: Active NMES
Sponsor:   CyMedica Orthopedics, Inc
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 10, 2019Comments OffEvaluation | Functional | Improving | Knee | NMES | Outcomes | Pain | Patients | Reducing
Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Conditions:   Amyloid;   Amyloidosis;   Spinal Stenosis;   Transthyretin Amyloidosis;   Primary Amyloidosis of Light Chain Type
Intervention:   Procedure: Biopsy
Sponsor:   The Cleveland Clinic
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 9, 2019Comments OffAmyloidosis | Flavum | Ligamentum | Screening | Systemic
L-Citrulline Dose Finding Safety Study in MELAS

Condition:   MELAS Syndrome
Intervention:   Drug: L-Citrulline
Sponsors:   Baylor College of Medicine;   National Institutes of Health (NIH);   University of South Florida;   Columbia University
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 8, 2019Comments OffDose | Finding | LCitrulline | MELAS | Safety | Study
Randomized Controlled Trial of Blood Flow Restriction + Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis

Condition:   Lateral Epicondylitis
Interventions:   Device: Blood flow restriction tourniquet;   Other: Evidence based physical/occupational therapy
Sponsor:   Akron General Medical Center
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 7, 2019Comments OffAlone | Blood | Controlled | Epicondylitis | Flow | Lateral | Physical | RAndomized | Restriction | Therapy | Trial
Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis

Condition:   Myositis
Intervention:   Drug: Celecoxib
Sponsor:   National Institute of Mental Health (NIMH)
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 5, 2019Comments OffArthritis | Biomarkers | Inflammatory | Myositis | Novel | Radioligands | Rheumatoid
Gait Retraining Enhances Athletes’ Technique

Conditions:   Anterior Cruciate Ligament Injury;   Knee Osteoarthritis
Intervention:   Other: Therapeutic Intervention
Sponsors:   Keller Army Community Hospital;   Telemedicine & Advanced Technology Research Center
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 4, 2019Comments OffAthletes | Enhances | Gait | Retraining | Technique
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

Condition:   Arthritis, Rheumatoid
Interventions:   Biological: GSK3196165;   Drug: Tofacitinib;   Drug: Placebo to GSK3196165;   Drug: Placebo to Tofacitinib;   Drug: csDMARDs
Sponsors:   GlaxoSmithKline;   IQVIA
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffActive | Antirheumatic | Arthritis | Conventional | cs/Biologic | Disease | DMARDs | Drugs | Efficacy | GSK3196165 | Inadequate | Moderately | Modifying | Participants | Placebo | Response | Rheumatoid | Safety | Severely | Synthetic | Tofacitinib | Versus
Biologic Therapy to Prevent Osteoarthritis After ACL Injury

Condition:   Anterior Cruciate Ligament Injuries
Interventions:   Drug: Anakinra injection;   Procedure: sterile saline injection
Sponsors:   University of California, Los Angeles;   Orthopedic Research and Education Foundation
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 1, 2019Comments OffAfter | Biologic | Injury | Osteoarthritis | Prevent | Therapy